Somaxon To Conduct Preclinical Tests On Its Phase III Insomnia Drug Silenor
FDA has requested that preclinical studies on low-dose doxepin be included in the 505(b)(2) application.
FDA has requested that preclinical studies on low-dose doxepin be included in the 505(b)(2) application.